| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Due from affiliates-Affiliated Entity | - | 346 | ||
| Cash and cash equivalents | 5,098,687 | 6,985,858 | ||
| Grants receivable | 302,643 | 257,407 | ||
| Prepaid expenses and other current assets | 204,720 | 287,419 | ||
| Total current assets | 5,606,050 | 7,531,030 | ||
| Total property and equipment | 1,706,075 | - | ||
| Less accumulated depreciation | 943,063 | - | ||
| Property and equipment, net | 763,012 | 821,305 | ||
| Operating lease right-of-use asset, net | 1,124,925 | 1,194,981 | ||
| Finance lease right-of-use asset, net | 119,236 | 129,593 | ||
| Income tax receivable | 105,826 | - | ||
| Total assets | 7,719,049 | 9,676,909 | ||
| Accounts payable | 904,353 | 930,629 | ||
| Due to affiliates | 17,085 | 0 | ||
| Operating lease liabilities current | 274,301 | 243,691 | ||
| Finance lease liabilities current | 42,623 | 42,623 | ||
| Total current liabilities | 1,238,362 | 1,216,943 | ||
| Deferred grant reimbursement | 103,065 | 116,119 | ||
| Operating lease liabilities - long term | 926,587 | 1,021,172 | ||
| Finance lease liabilities - long term | 76,613 | 86,970 | ||
| Total liabilities | 2,344,627 | 2,441,204 | ||
| Common shares, 100,000,000 authorized shares at 0.000001 8,387,250 and 8,367,810 shares issued and outstanding as of september 30, 2025, and december 31, 2024, respectively | 8 | 8 | ||
| Additional paid-in-capital | 23,824,070 | 23,398,362 | ||
| Accumulated (deficit) | -18,449,656 | -16,162,665 | ||
| Total stockholders equity | 5,374,422 | 7,235,705 | ||
| Total liabilities and equity | 7,719,049 | 9,676,909 | ||
EXOZYMES INC. (EXOZ)
EXOZYMES INC. (EXOZ)